** Max Healthcare Institute MAXE.NS shares up ~8.6% to
871.2 rupees, highest since mid-April
** Brokerage Ambit says the heathcare services co holds
dominance in brownfield market segment sees MAXE's bed-addition
plans as most aggressive among peers
** Adds, higher brownfield expansion plans in core market
regions such as Delhi, Lucknow are key drivers of co's core
profit growth
** Sees MAXE as second-top hospitals pick following Narayana
Hrudayalaya NARY.NS
** Maintains "Buy" rating on stock; PT of 920 rupees/share
unchanged, at ~15% premium on last close
** Stock on track to log biggest one-day percentage gain
since Sept. 2022
** Analysts' avg rating on stock is "Buy", median PT is 885
rupees - LSEG data
** Including session's gains, stock is up ~27% YTD vs ~17%
rise in the Nifty mid-cap index .NIFMDCP100
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))